Supported by a staff of professional scientists and rich experience in the research of neuroscience, Creative Biolabs provides a full range of high-quality neural cell line products. Learn more, https://neuros.creative-biolabs.com/category-neural-cell-lines-42.htm.
In Vitro Neuroscience Services-Creative Biolabscailynnjohnson
Creative Biolabs' dedicated team of neuroscience CRO scientists want the same thing as you do: to find a cure for the devastating diseases of the central nervous system.
https://neuros.creative-biolabs.com/
BrainBits provides fresh, dissected neural tissues from mice and rats to neuroscience researchers. It sources animals ethically and dissects tissues with expertise to reduce animal use. Researchers can order specific tissues and receive overnight shipments, avoiding delays from establishing internal tissue programs. BrainBits has 15+ years of experience serving over 800 labs annually. Using its centralized tissue processing allows many more labs to complete their research using far fewer total animals compared to processing tissues individually.
The document summarizes a presentation on generating cerebral organoids with a single progenitor zone. It describes how organoids formed from different initial cell numbers were analyzed. Organoids with higher initial cell numbers were larger with more progenitor zones, while lower cell numbers led to smaller organoids with fewer zones. Both hypoxic and apoptotic markers accumulated in the centers of most organoids. Future work will involve additional cell seeding trials with lower cell numbers and longer development to better control the structure of generated organoids.
DV Biologics is a global supplier of human biological materials including a library of disease-specific and normal cells, media, and genomics products. They offer custom cell procurement and characterization services, and their quality-controlled products are used in drug discovery and development by biopharmaceutical companies and research institutes. DV Biologics provides a wide range of cellular systems, normal and diseased primary cells, proteomic and genomic tools, and optimized cell culture media to support research and drug development.
This study developed an in vitro model for differentiating human pluripotent stem cells into retinal neurons. The differentiation process followed identifiable stages of retinal development:
1) Undifferentiated stem cells expressed pluripotent markers.
2) After 10 days of differentiation, eye field populations expressed neural and eye field transcription factors.
3) By day 30, retinal progenitor neurospheres analogous to the optic vesicle expressed retinal progenitor markers.
4) At day 70, the stem cells yielded retinal ganglion cells and photoreceptor cells, demonstrating the ability to derive major retinal cell types.
This document discusses neural progenitor cells (NPCs), which are potent models for studying normal and diseased neurobiology. The author describes how ATCC has developed NPC lines from various sources including induced pluripotent stem cells. NPCs can be expanded and differentiated into neurons, astrocytes and oligodendrocytes. ATCC has optimized culture conditions for NPC growth and differentiation. Reporter NPC lines expressing GFP, NanoLuc, or HaloTag have also been generated. Initial NPC offerings from ATCC are outlined. In summary, ATCC provides a complete solution of NPCs and culture media for disease modeling and drug screening applications.
In Vitro Neuroscience Services-Creative Biolabscailynnjohnson
Creative Biolabs' dedicated team of neuroscience CRO scientists want the same thing as you do: to find a cure for the devastating diseases of the central nervous system.
https://neuros.creative-biolabs.com/
BrainBits provides fresh, dissected neural tissues from mice and rats to neuroscience researchers. It sources animals ethically and dissects tissues with expertise to reduce animal use. Researchers can order specific tissues and receive overnight shipments, avoiding delays from establishing internal tissue programs. BrainBits has 15+ years of experience serving over 800 labs annually. Using its centralized tissue processing allows many more labs to complete their research using far fewer total animals compared to processing tissues individually.
The document summarizes a presentation on generating cerebral organoids with a single progenitor zone. It describes how organoids formed from different initial cell numbers were analyzed. Organoids with higher initial cell numbers were larger with more progenitor zones, while lower cell numbers led to smaller organoids with fewer zones. Both hypoxic and apoptotic markers accumulated in the centers of most organoids. Future work will involve additional cell seeding trials with lower cell numbers and longer development to better control the structure of generated organoids.
DV Biologics is a global supplier of human biological materials including a library of disease-specific and normal cells, media, and genomics products. They offer custom cell procurement and characterization services, and their quality-controlled products are used in drug discovery and development by biopharmaceutical companies and research institutes. DV Biologics provides a wide range of cellular systems, normal and diseased primary cells, proteomic and genomic tools, and optimized cell culture media to support research and drug development.
This study developed an in vitro model for differentiating human pluripotent stem cells into retinal neurons. The differentiation process followed identifiable stages of retinal development:
1) Undifferentiated stem cells expressed pluripotent markers.
2) After 10 days of differentiation, eye field populations expressed neural and eye field transcription factors.
3) By day 30, retinal progenitor neurospheres analogous to the optic vesicle expressed retinal progenitor markers.
4) At day 70, the stem cells yielded retinal ganglion cells and photoreceptor cells, demonstrating the ability to derive major retinal cell types.
This document discusses neural progenitor cells (NPCs), which are potent models for studying normal and diseased neurobiology. The author describes how ATCC has developed NPC lines from various sources including induced pluripotent stem cells. NPCs can be expanded and differentiated into neurons, astrocytes and oligodendrocytes. ATCC has optimized culture conditions for NPC growth and differentiation. Reporter NPC lines expressing GFP, NanoLuc, or HaloTag have also been generated. Initial NPC offerings from ATCC are outlined. In summary, ATCC provides a complete solution of NPCs and culture media for disease modeling and drug screening applications.
BrainPlotting is a CRO dedicated to studying pharmacokinetics in the human brain at preclinical stages. It uses the most accurate predictive models and recent methods, such as proprietary in vitro models based on primary human cells and tissues, to generate high-accuracy predictive models of molecules' brain exposure. BrainPlotting can predict human brain concentrations and clinical PK information from preclinical data through techniques like determining blood-brain barrier permeability, unbound fractions in plasma and brain, and physiologically-based PK modeling specific to humans.
Creative Biolabs' dedicated team of neuroscience CRO scientists want the same thing as you do: to find a cure for the devastating diseases of the central nervous system. Learn more, please visit https://neuros.creative-biolabs.com/antibody-discovery-services.htm.
This seminar presentation summarizes research on chemoarchitectonics and neural growth factors. It discusses chemoarchitectonics as the study of brain anatomy and function through staining specific chemicals to identify neurotransmitter patterns. The presentation reviews a study on lungfish brains that identified neuronal populations and tracts using calbindin and calretinin staining. It also discusses Brodmann's cytoarchitectonic mapping of the cerebral cortex and Nissl staining technique. Finally, it provides an overview of neurotrophins like NGF, their discovery, biogenesis, functions in neuron survival and differentiation, and signaling mechanisms through neurotrophin receptors.
Potential Therapeutic Application Of Stem CellStefanus Nofa
Potential therapeutic applications of stem cells include treating many diseases. Stem cells can differentiate into other cell types and can self-renew. Embryonic stem cells are pluripotent and can differentiate into all germ layers but have ethical issues. Adult stem cells are multipotent and are found in tissues but are limited in differentiation. Stem cell therapies show promise for diseases like Parkinson's, diabetes, and heart disease. Challenges include controlling differentiation and reducing tumor risks. The stem cell market is growing rapidly with applications in regenerative medicine and drug development.
This document provides an overview of the field of bioinformatics. It discusses that bioinformatics is the analysis of biological information using computers and statistical techniques, and involves organizing, storing, analyzing and visualizing genomic data. It also discusses various databases used in bioinformatics, including nucleotide sequence databases like GenBank, protein sequence databases like Swiss-Prot, structure databases like PDB, and species-oriented databases. Examples of analyzing genomic sequences, predicting protein structures, and correlating gene expression and disease are also provided.
Detecting Nuclei from Microscopy Images with Deep LearningDmytro Fishman
The document describes an automated microscopy image analysis pipeline using deep learning. It begins with preprocessing the original image, including filtering, contrast adjustment, and denoising. Next, a convolutional neural network is used to directly perform pixel-wise segmentation of the image without needing separate object detection or thresholding steps. The network is trained on extracted image patches labeled as nuclei or empty background. Once trained, it can quickly segment new microscopy images, classifying each pixel. This deep learning approach is much faster than traditional pipelines and avoids issues with hand-tuning thresholds.
This study analyzed changes in chromatin architecture throughout zebrafish development. The researchers found:
1. Chromatin accessibility changes significantly during development, with many regions gaining or losing accessibility.
2. Early development involves genome-wide loss of accessibility, while later stages see more region-specific changes.
3. Accessible regions often correspond to active gene regulatory elements, and changes in accessibility correlate with changes in gene expression.
The Neuroscience Information Framework (NIF) uses ontologies like the NIF Standard Ontology (NIFSTD) to enable concept-based search across multiple neuroscience resources. NIFSTD integrates over 60,000 concepts from various domains of neuroscience and reuses terms from existing ontologies. It allows for classification of neuroscience entities and logical inferences to find related concepts. The NIF framework aims to build a rich knowledgebase integrating neuroscience data from various sources.
Biotechnology applies biological knowledge to enhance the environment, health, and food supply. It uses organisms, cells, and molecules to solve problems and make useful products. Key technologies include bioprocessing to manufacture products using bacteria and cells, monoclonal antibodies for medicine, cell culture, tissue engineering, genetic engineering to modify organisms, bioinformatics to study biology computationally, and DNA chips to analyze genes. Biotechnology has medical applications like disease detection and treatment, agricultural applications to develop hardier crops and livestock, and environmental uses such as bioremediation. However, advances raise ethical issues around food safety, privacy, cloning, and responsible development.
Cell Therapy Industry News Round-Up - September 13, 2022 [BioInformant]BioInformant
The document discusses several topics related to stem cells and regenerative medicine:
1) It provides an overview of 10 scientists nominated for a $100,000 stem cell research grant to be awarded in October.
2) It describes a new collaboration between RoosterBio and AGC Biologics to accelerate manufacturing of cell and exosome therapies.
3) It announces that Steakholder Foods will begin developing cultured pork products using induced pluripotent stem cells.
Cell based assays presentation v3_03_2012Pete Shuster
Update presentation on "increasing returns in drug discovery by harnessing the power of cells". Includes images/data/pubs of differentiating human sensory and dopaminergic neurons from hNP1 neural progenitors + osteoblasts and chondrocytes from human mesenchymal stem cells. Our platforms are ideal for high throughput screening and other drug discovery processes.
Cell based assays presentation V2_03_2012Pete Shuster
This document provides an executive overview of a company called Neuromics/Vitro Biopharma that develops pre-clinical tools for drug discovery using human stem cell-derived cell systems. The company offers physiologically relevant human cells and cellular systems to enable better in vitro screening and target identification, reducing animal models and shortening development timelines. Key offerings include human stem cell-derived neuronal cells, glial cells, immune cells and other cell types, specialized media, transfection reagents, markers and labeling technologies. The company aims to improve early drug discovery through more predictive human cell-based assays.
126 micro array study for gene expressionSHAPE Society
The document describes the process of performing a microarray study to analyze gene expression. It discusses the history of microarrays and the overall process which includes building the chip by amplifying cDNA clones via PCR, preparing RNA by isolating it from cell cultures, hybridizing the array by labeling probes with fluorescent dyes and incubating RNA samples on the chip, and analyzing the data by quantifying fluorescence levels. The goal is to induce rupture of atherosclerotic plaques in mice and use microarrays to identify genes expressed in ruptured versus stable plaques. Various drugs will be tested for their ability to rupture plaques by altering hemodynamics and oxidative stress.
This document summarizes cell-based assay solutions from Neuromics and its partnership with UB Systems. It describes 3D cell-based assays including blood-brain barrier models and extracellular matrix hydrogels. It also provides details on various human brain cell types such as endothelial cells, astrocytes, and pericytes that can be used to build customized 3D brain models. Additionally, it mentions services offered like media filling and various cell culture reagents including fetal bovine serum in different grades.
The blue brain, a Swiss national brain initiative, aims to create a digital reconstruction of the brain by REVERSE ENGINEERING mammalian brain circuitry.
Differentiation of neural_cells_in_human_embryonic_stemHoney Cheng
The document discusses neural differentiation from human and mouse embryonic stem cells. It outlines inducing neural differentiation from hESCs through various stages, including rosette formation and differentiation into neural precursor cells, neurons, astrocytes, and oligodendrocytes. Methods of identifying differentiated cell types using immunocytochemistry and markers are also presented. The document also briefly discusses the linkage between neural cells and retinal cells during embryonic development.
The document discusses neural differentiation from human and mouse embryonic stem cells. It outlines inducing neural differentiation from hESCs through various stages, including rosette formation and differentiation into neural precursor cells, neurons, astrocytes, and oligodendrocytes. Methods for identifying and characterizing the differentiated neural cell types are also presented, such as immunocytochemical staining and electrophysiological recording. The linkage between neural cells and retinal cells is briefly discussed.
The document discusses microarray studies to analyze gene expression. It provides background on the history and evolution of cDNA microarrays. It then describes the basic process of building microarray chips, preparing RNA samples, hybridizing chips, and analyzing data. Specific details are given on preparing probes, synthesizing oligonucleotides, making microarray chips in the lab, obtaining tissue samples, and analyzing emission from hybridized chips. The overall aim is to induce rupture of atherosclerotic plaques in mice and use microarrays to find genes expressed in ruptured plaques by comparing results to histopathology. Various drugs being tested to induce rupture are also listed.
The document provides information on NeuroGen Brain and Spine Institute, an international centre of excellence for neurological disorders that has treated over 7,000 patients from 65 countries. NeuroGen uses a combination of stem cell therapy and neurorehabilitation to treat various neurological conditions such as autism, cerebral palsy, spinal cord injury, and stroke, employing patient's own bone marrow-derived stem cells in a minimally invasive procedure. The institute has received several national and international awards for its treatment protocols and research publications.
Creative Biolabs has extensive experience in complement test, providing customers with a full range of test services, including complement function/activity test, autoantibody test, and genetic test, which address the significantly unmet need for accurate and timely diagnosis and monitoring of complement-related disease. Learn more, https://www.creative-biolabs.com/complement-therapeutics/complement-test-services.htm.
With extensive experience and advanced platforms, we can provide a series of AI-augmented antibody discovery services for research, diagnostics, and therapeutics. Learn more, please visit https://ai.creative-biolabs.com/ai-augmented-antibody-discovery.htm.
More Related Content
Similar to Neuros Cell Line Products-Creative Biolabs
BrainPlotting is a CRO dedicated to studying pharmacokinetics in the human brain at preclinical stages. It uses the most accurate predictive models and recent methods, such as proprietary in vitro models based on primary human cells and tissues, to generate high-accuracy predictive models of molecules' brain exposure. BrainPlotting can predict human brain concentrations and clinical PK information from preclinical data through techniques like determining blood-brain barrier permeability, unbound fractions in plasma and brain, and physiologically-based PK modeling specific to humans.
Creative Biolabs' dedicated team of neuroscience CRO scientists want the same thing as you do: to find a cure for the devastating diseases of the central nervous system. Learn more, please visit https://neuros.creative-biolabs.com/antibody-discovery-services.htm.
This seminar presentation summarizes research on chemoarchitectonics and neural growth factors. It discusses chemoarchitectonics as the study of brain anatomy and function through staining specific chemicals to identify neurotransmitter patterns. The presentation reviews a study on lungfish brains that identified neuronal populations and tracts using calbindin and calretinin staining. It also discusses Brodmann's cytoarchitectonic mapping of the cerebral cortex and Nissl staining technique. Finally, it provides an overview of neurotrophins like NGF, their discovery, biogenesis, functions in neuron survival and differentiation, and signaling mechanisms through neurotrophin receptors.
Potential Therapeutic Application Of Stem CellStefanus Nofa
Potential therapeutic applications of stem cells include treating many diseases. Stem cells can differentiate into other cell types and can self-renew. Embryonic stem cells are pluripotent and can differentiate into all germ layers but have ethical issues. Adult stem cells are multipotent and are found in tissues but are limited in differentiation. Stem cell therapies show promise for diseases like Parkinson's, diabetes, and heart disease. Challenges include controlling differentiation and reducing tumor risks. The stem cell market is growing rapidly with applications in regenerative medicine and drug development.
This document provides an overview of the field of bioinformatics. It discusses that bioinformatics is the analysis of biological information using computers and statistical techniques, and involves organizing, storing, analyzing and visualizing genomic data. It also discusses various databases used in bioinformatics, including nucleotide sequence databases like GenBank, protein sequence databases like Swiss-Prot, structure databases like PDB, and species-oriented databases. Examples of analyzing genomic sequences, predicting protein structures, and correlating gene expression and disease are also provided.
Detecting Nuclei from Microscopy Images with Deep LearningDmytro Fishman
The document describes an automated microscopy image analysis pipeline using deep learning. It begins with preprocessing the original image, including filtering, contrast adjustment, and denoising. Next, a convolutional neural network is used to directly perform pixel-wise segmentation of the image without needing separate object detection or thresholding steps. The network is trained on extracted image patches labeled as nuclei or empty background. Once trained, it can quickly segment new microscopy images, classifying each pixel. This deep learning approach is much faster than traditional pipelines and avoids issues with hand-tuning thresholds.
This study analyzed changes in chromatin architecture throughout zebrafish development. The researchers found:
1. Chromatin accessibility changes significantly during development, with many regions gaining or losing accessibility.
2. Early development involves genome-wide loss of accessibility, while later stages see more region-specific changes.
3. Accessible regions often correspond to active gene regulatory elements, and changes in accessibility correlate with changes in gene expression.
The Neuroscience Information Framework (NIF) uses ontologies like the NIF Standard Ontology (NIFSTD) to enable concept-based search across multiple neuroscience resources. NIFSTD integrates over 60,000 concepts from various domains of neuroscience and reuses terms from existing ontologies. It allows for classification of neuroscience entities and logical inferences to find related concepts. The NIF framework aims to build a rich knowledgebase integrating neuroscience data from various sources.
Biotechnology applies biological knowledge to enhance the environment, health, and food supply. It uses organisms, cells, and molecules to solve problems and make useful products. Key technologies include bioprocessing to manufacture products using bacteria and cells, monoclonal antibodies for medicine, cell culture, tissue engineering, genetic engineering to modify organisms, bioinformatics to study biology computationally, and DNA chips to analyze genes. Biotechnology has medical applications like disease detection and treatment, agricultural applications to develop hardier crops and livestock, and environmental uses such as bioremediation. However, advances raise ethical issues around food safety, privacy, cloning, and responsible development.
Cell Therapy Industry News Round-Up - September 13, 2022 [BioInformant]BioInformant
The document discusses several topics related to stem cells and regenerative medicine:
1) It provides an overview of 10 scientists nominated for a $100,000 stem cell research grant to be awarded in October.
2) It describes a new collaboration between RoosterBio and AGC Biologics to accelerate manufacturing of cell and exosome therapies.
3) It announces that Steakholder Foods will begin developing cultured pork products using induced pluripotent stem cells.
Cell based assays presentation v3_03_2012Pete Shuster
Update presentation on "increasing returns in drug discovery by harnessing the power of cells". Includes images/data/pubs of differentiating human sensory and dopaminergic neurons from hNP1 neural progenitors + osteoblasts and chondrocytes from human mesenchymal stem cells. Our platforms are ideal for high throughput screening and other drug discovery processes.
Cell based assays presentation V2_03_2012Pete Shuster
This document provides an executive overview of a company called Neuromics/Vitro Biopharma that develops pre-clinical tools for drug discovery using human stem cell-derived cell systems. The company offers physiologically relevant human cells and cellular systems to enable better in vitro screening and target identification, reducing animal models and shortening development timelines. Key offerings include human stem cell-derived neuronal cells, glial cells, immune cells and other cell types, specialized media, transfection reagents, markers and labeling technologies. The company aims to improve early drug discovery through more predictive human cell-based assays.
126 micro array study for gene expressionSHAPE Society
The document describes the process of performing a microarray study to analyze gene expression. It discusses the history of microarrays and the overall process which includes building the chip by amplifying cDNA clones via PCR, preparing RNA by isolating it from cell cultures, hybridizing the array by labeling probes with fluorescent dyes and incubating RNA samples on the chip, and analyzing the data by quantifying fluorescence levels. The goal is to induce rupture of atherosclerotic plaques in mice and use microarrays to identify genes expressed in ruptured versus stable plaques. Various drugs will be tested for their ability to rupture plaques by altering hemodynamics and oxidative stress.
This document summarizes cell-based assay solutions from Neuromics and its partnership with UB Systems. It describes 3D cell-based assays including blood-brain barrier models and extracellular matrix hydrogels. It also provides details on various human brain cell types such as endothelial cells, astrocytes, and pericytes that can be used to build customized 3D brain models. Additionally, it mentions services offered like media filling and various cell culture reagents including fetal bovine serum in different grades.
The blue brain, a Swiss national brain initiative, aims to create a digital reconstruction of the brain by REVERSE ENGINEERING mammalian brain circuitry.
Differentiation of neural_cells_in_human_embryonic_stemHoney Cheng
The document discusses neural differentiation from human and mouse embryonic stem cells. It outlines inducing neural differentiation from hESCs through various stages, including rosette formation and differentiation into neural precursor cells, neurons, astrocytes, and oligodendrocytes. Methods of identifying differentiated cell types using immunocytochemistry and markers are also presented. The document also briefly discusses the linkage between neural cells and retinal cells during embryonic development.
The document discusses neural differentiation from human and mouse embryonic stem cells. It outlines inducing neural differentiation from hESCs through various stages, including rosette formation and differentiation into neural precursor cells, neurons, astrocytes, and oligodendrocytes. Methods for identifying and characterizing the differentiated neural cell types are also presented, such as immunocytochemical staining and electrophysiological recording. The linkage between neural cells and retinal cells is briefly discussed.
The document discusses microarray studies to analyze gene expression. It provides background on the history and evolution of cDNA microarrays. It then describes the basic process of building microarray chips, preparing RNA samples, hybridizing chips, and analyzing data. Specific details are given on preparing probes, synthesizing oligonucleotides, making microarray chips in the lab, obtaining tissue samples, and analyzing emission from hybridized chips. The overall aim is to induce rupture of atherosclerotic plaques in mice and use microarrays to find genes expressed in ruptured plaques by comparing results to histopathology. Various drugs being tested to induce rupture are also listed.
The document provides information on NeuroGen Brain and Spine Institute, an international centre of excellence for neurological disorders that has treated over 7,000 patients from 65 countries. NeuroGen uses a combination of stem cell therapy and neurorehabilitation to treat various neurological conditions such as autism, cerebral palsy, spinal cord injury, and stroke, employing patient's own bone marrow-derived stem cells in a minimally invasive procedure. The institute has received several national and international awards for its treatment protocols and research publications.
Similar to Neuros Cell Line Products-Creative Biolabs (20)
Creative Biolabs has extensive experience in complement test, providing customers with a full range of test services, including complement function/activity test, autoantibody test, and genetic test, which address the significantly unmet need for accurate and timely diagnosis and monitoring of complement-related disease. Learn more, https://www.creative-biolabs.com/complement-therapeutics/complement-test-services.htm.
With extensive experience and advanced platforms, we can provide a series of AI-augmented antibody discovery services for research, diagnostics, and therapeutics. Learn more, please visit https://ai.creative-biolabs.com/ai-augmented-antibody-discovery.htm.
Creative Biolabs' dedicated team of neuroscience CRO scientists want the same thing as you do: to find a cure for the devastating diseases of the central nervous system.
https://neuros.creative-biolabs.com/
This study developed a fluorescent cell-based assay to screen compounds that can prevent the aggregation of α-synuclein protein in neuronal cells. SH-SY5Y cell lines expressing green or red fluorescent tagged α-synuclein were treated with staurosporine to induce aggregation. A library of 100 compounds was screened for ability to reduce aggregation. Compounds showing over 25% reduction without toxicity were selected for dose response analysis. The assay demonstrated robust performance (Z’>0.5) for high-content screening of potential drugs to treat Parkinson’s disease.
As one of the most experienced and responsible companies in the T cell therapy development field, Creative Biolabs provides a range of γδ T cell cytotoxicity test services for our clients, including lactate dehydrogenase (LDH) cytotoxicity test.
Creative Biolabs is supported by an advisory board with seasoned professionals in gamma delta T cell receptors (γδ TCR) studies, γδ T cell immunologic analysis, as well as γδ T cell therapy development. We have accumulated extensive experience from the accomplishment of different projects, during which we have received a lot of recognition and praise from our clients.
Gamma delta (γδ) T cells have shown promising treatment for infectious diseases and certain types of cancers. As one of the top CRO companies in the field of γδ T cell therapy development for disease therapy, Creative Biolabs has focused on γδ T cell engineering services for years and has accomplished numerous challenging projects in this field. Equipped with deep knowledge and experience in γδ T cell design, we can offer high-quality custom γδ T cell solutions for our valued clients.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Neuros Cell Line Products-Creative Biolabs
1. Neural Cell Lines
TEL: 1-631-357-2254
E-mail: info@creative-biolabs.com
SUITE 203, 17 Ramsey Road, Shirley, NY 11967, USA
neuros.creative-biolabs.com
2. Cutting Edge Tools for Neuroscience Research
In 2005, Creative Biolabs opened its doors offering neuroscience research antibodies with the goal of putting customers first.
From day one, our vision has been to provide products you can trust. We stand behind our products—leading us to create our
policy of replacing or refunding reagents or cells that do not meet expectations.
As our number of loyal and satisfied customers grow, so do our offerings. Our selection of antibodies has expanded, along
with other products, including human cells, specialized media, sera, and cell models. We continue to assess the needs of the
neuroscience research field and add new resources to our neuroscience range to add to our cutting edge technologies.
Currently, Creative Biolabs offers a range of specific tools & reagents to allow you stay at the forefront of your field. Creative
Biolabs is your source for neural cells, media and supplements including iPSC-derived cells. Our large range of substrates
and matrices including natural extracellular matrices and artificial scaffolds gives you numerous options to develop your in
vitro system. We also offer innovative neural tracers and customized technical services that help researchers explore
questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases. We
also have an extensive biorepository with neural tissue from numerous species. We will always offer proven reagents for
results you can trust and understand.
Cutting Edge Tools for Neuroscience Research
3. Neural Cell Lines
Neural Stem Cells
Neural Progenitor Cells
Neurons
Astrocytes
Microglial Cells
Oligodendrocytes
Schwann Cells
Neurological Disease Cell Models
Neural Tissues
Neural Cell Culture Media and Supplements
Neural Cell Culture Matrices
Neural Cell Transfection
Neural Cell Cryopreservation
Cutting Edge Tools for Neuroscience Research
Table of Contents
4. Cellular models are highly important tools for numerous applications in neuroscience, for example the study of
neurodegeneration, neurogenesis and developmental diseases. There is also a growing sense of the importance of studying
the behaviour of neurons, glial cells and neural stem cells within a physiologically relevant context. Creative Biolabs offers a
range of cryopreserved human, mouse and rat neural cells and neurological disease models to allow you stay at the forefront
of your field. With years of experience in primary neural cell isolation, Creative Biolabs offers ready-to use, high quality primary
neural cells for your research. Extensive testing and optimization provides quality and performance of our neural cells with
every batch produced. Creative Biolabs' portfolio also includes reliable neural media products (see page 16 ) that are
optimized and tested specifically with our neural cells. Creative Biolabs guarantees the performance of its cells when cultured
with the recommended medium and following the protocol.
Neuron Microglia Astrocyte
Oligodendrocyte
Neural Stem Cell
Neural Progenitor Cell
Neural Cell Lines
Cutting Edge Tools for Neuroscience Research
5. Neural stem cells are undifferentiated cells found within the brain. They were first described in the subventricular zone (SVZ) by
Sally Temple in 1-8- but were not isolated until 1--2 from adult striatal tissue by Brent Reynolds. Like mesenchymal stem cells,
neural stem cells have the capacity to undergo extensive cell divisions in vitro and are multipotent in nature.
Human iPSC-derived Neural Stem Cells from Healthy Donors
Cat. Product Name Starting Material Quantity
NCL-2101-ZP01 Human iPSC-Derived Neural Stem Cells (Male), Source Cord Blood CD34+ Cells Cord Blood CD34+ Cells
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP02
Human iPSC-Derived Neural Stem Cells (Male), Source Cord Blood CD34+ Cells,
Validated
Cord Blood CD34+ Cells
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP03 Human iPSC-Derived Neural Stem Cells (Female), Source Cord Blood CD34+ Cells Cord Blood CD34+ Cells
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP04
Human iPSC-Derived Neural Stem Cells (Male), Source Fibroblasts (74 Yr Donor),
Validated
Fibroblasts (74 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP05 Human iPSC-Derived Neural Stem Cells (Female), Source Fibroblasts (64 Yr Donor) Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
Human iPSC-derived Neural Stem Cells from Patient Donors
Cat. Product Name Starting Material Quantity
NCL-2101-ZP06 Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (APOE4 HOM) Fibroblasts (87 Yr Female)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP07 Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (PSEN1 L286V) Fibroblasts (38 Yr Female)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP08 Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (PSEN1 M146L) Fibroblasts (53 Yr Male)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP0- Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (PSEN1 A246E) Fibroblasts (31 Yr Female)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP10 Human iPSC-Derived Neural Stem Cells - Huntington's Disease Patient Fibroblasts (48 Yr Female)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP11 Human iPSC-Derived Neural Stem Cells - Epilepsy Patient Fibroblasts (5 Mo Female)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP12 Human iPSC-Derived Neural Stem Cells - Trisomy X Patient Fibroblasts (74 Yr Female)
1.5 million cells & Neural Plating-XF
Medium
CRIGEM™ Genetically Edited Human iPSC-derived Neural Stem Cells
Cat. Product Name Starting Material Quantity
NCL-2101-ZP05 Human iPSC-Derived Neural Stem Cells (Female), Source Fibroblasts (64 Yr Donor) Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP14 CRIGEM™ iPSC-Derived Neural Stem Cells LRRK2 G201-S HOM Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP15 CRIGEM™ iPSC-Derived Neural Stem Cells LRRK2 G201-S HET Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP16 CRIGEM™ iPSC-Derived Neural Stem Cells MAPT R406W HET Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP17 CRIGEM™ iPSC-Derived Neural Stem Cells MAPT V337M HOM Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP18 CRIGEM™ iPSC-Derived Neural Stem Cells MAPT V337M HET Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP1- CRIGEM™ iPSC-Derived Neural Stem Cells MAPT P301L HOM Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
NCL-2101-ZP20 CRIGEM™ iPSC-Derived Neural Stem Cells MAPT P301L HET Fibroblasts (64 Yr Donor)
1.5 million cells & Neural Plating-XF
Medium
Cat. Product Name Cell Type
NCL-2105-P205-AM Mouse Embryo Neural Stem Cells, Immortalized Immortalized Cell
NCL-2108P23 Mouse Neural Stem Cells Ne-4C Immortalized Cell
NCL-2108P25 Mouse Neural Stem Cells C17.2 Immortalized Cell
NCL-2105-C356 Mouse Neural Stem Cells, Adult Primary Cell
NCL-2105-F356 Mouse Neural Stem Cells, Fetal Primary Cell
NCL-2108-P016 Mouse Cortical Neural Stem Cells Primary Cell
NCL-2108-P017 Mouse Spinal Cord Neural Stem Cells Primary Cell
NCL-2105-P242-AM Rat Neural Stem Cells (1464R), Immortalized Immortalized Cell
NCL-2108-P01- Rat Neural Stem Cells, Adult Primary Cell
NCL-2108-F01- Rat Neural Stem Cells, Fetal Primary Cell
NCL-2108-C001 Rat Neural Stem Cells Fetal (E14 cortex) Primary Cell
Neural Cell Lines
Mouse/Rat Neural Stem Cells
Cutting Edge Tools for Neuroscience Research
Human iPSC-Derived Neural Stem Cells
6. Since the discovery that neural progenitor cells (NPCs) from induced pluripotent stem cells (iPSCs) can proliferate or
differentiate into neurons, oligodendrocytes, or astrocytes, NPCs are becoming an attractive in vitro model to study
neurological development and neurotoxicity and to model diseases.
Creative Biolabs’ NPCs are derived from a collection of well-characterized, integration-free reprogrammed iPSCs. For
investigators looking to reduce the time from initial culture to experiment readout, our NPCs can eliminate the 4 to 8 weeks for
iPSCs to differentiate into NPCs.
Creative Biolabs provides a complete system of NPC solutions for investigating development, degeneration and regeneration,
neurogenetics, neural excitability, nervous system disorders, neurotransmitters, and screening therapeutics.
• Normal and neurological disease iPSC-derived NPCs
• Gene-edited, lineage-specific reporter NPCs
• Expansion and differentiation media kits
• Validated growth and differentiation protocols
Cat. Product Name Cell Type
NCL-2108-P001 Human Neural Progenitor Cells, Fully Validated Primary Cell
NCL-21P6-17- Human Neural Progenitor Cell Line, Cortical Derived Primary Cell
NCL-2105-P11-HP NeuCell™ Human GABAergic Neural Progenitor Cells (GPC), 1M Primary Cell
NCL-2105-P17-HP NeuCell™ Human Motor Neural Progenitor Cells (MPC), 1M Primary Cell
NCL-2105-P2--HP NeuCell™ Human Dopaminergic Neural Progenitor Cells (DPC), 1M Primary Cell
NCL-2105-P33-HP NeuCell™ Human Glutamatergic Neural Progenitor Cells (GPC), 1M Primary Cell
NCL200506ZP Human Oligodendrocyte Progenitor Cells Primary Cell
NCL-2105-P187-AM Human Cranial Suture Progenitor Cells (iSuPs), Immortalized Immortalized Cell
NCL-2108P147 Human Neuron Progenitor Cells (Neu41), Immortalized Immortalized Cell
NCL200501ZP Human Neural Progenitor Cell Line, Cortical Derived, Immortalized Immortalized Cell
NCL-21P6-212 Human Neural Progenitor Cell Line, Ventral Mesencephalon Derived, Immortalized Immortalized Cell
NCL-2108-P002 NeuCELL™ VM Human Neural Progenitor Cell Line, Immortalized Immortalized Cell
NCL-2108-P003 NeuCELL™ CX Human Neural Progenitor Cell Line, Immortalized Immortalized Cell
NCL-2105-P211-AM Mouse Neural Progenitor Cells, Immortalized Immortalized Cell
NCL-2105-P276-AM Mouse Pituitary Progenitor Cells (αT1-1), Immortalized Immortalized Cell
NCL-2105-P247-AM Rat Sympathoadrenal Progenitor Cells (MAH-A3), Immortalized Immortalized Cell
NCL-2108-P007 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone A4H1 Disease Model
NCL-2108-P008 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone D4 Disease Model
NCL-2108-P00- Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone B2 Disease Model
NCL-2108-P010 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone 3C1 Disease Model
NCL-2108-P011 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone A5 Disease Model
NCL-2108-P012 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone E6F4 Disease Model
NCL-2108-P013 Alzheimer's 3Dish™ NeuCELL™ VM Human Neural Progenitor Cell Line, Clone H10 Disease Model
Neural Progenitor Cells
Selected Neural Progenitor Cell Lines
Cutting Edge Tools for Neuroscience Research
7. Neurons (also called neurones or nerve cells) are the fundamental units of the brain and nervous system, the cells responsible
for receiving sensory input from the external world, for sending motor commands to our muscles, and for transforming and
relaying the electrical signals at every step in between.
Creative Biolabs supplies a number of high viability cryopreserved and live primary neurons which are ideal for studying
mechanisms of developmental neurobiology, disease progression, neurotoxicology and other areas of neuroscience.
Human Neurons
Cat. Product Name Cell Type
NCL-2103-P71 iNeu™ Human iPSC-derived Motor Neurons Primary Cell
NCL-2103-P77 iNeu™ Human iPSC-derived Dopaminergic Neurons Primary Cell
NCL-2103-P78 iNeu™ Human iPSC-derived Cortical Neurons Primary Cell
NCL-2103-P62 iNeu™ Human iPSC-derived Sensory Neurons Primary Cell
NCL-21P6-001 iNeu™ Human iPSC-derived Spinal Motor Neurons Primary Cell
NCL-21P6-002 iNeu™ Human iPSC-derived Layer V Glutamatergic Neurons Primary Cell
NCL-21P6-003 iNeu™ Human iPSC-derived Midbrain Dopaminergic Neurons Primary Cell
NCL-21P6-004 iNeu™ Human iPSC-derived Cortical GABAergic Neurons Primary Cell
NCL-21P6-005 iNeu™ Human iPSC-derived Cortical Glutamatergic Neurons Primary Cell
NCL-21P6-007 iNeu™ Human iPSC-derived Mixed Cortical Neurons Primary Cell
NCL-21P6-008 iNeu™ Human iPSC-derived Medium Spiny Neurons Primary Cell
NCL-21P6-025 Human Hippocampus-derived Neurons Primary Cell
NCL-21P6-172 Human Midbrain-derived Neurons Primary Cell
NCL-21P6-027 Human Brain Stem-derived Neurons Primary Cell
NCL2110P18- Human Cortical-derived Neurons Primary Cell
NCL-2105-P130-IX Human iPSC-derived Motor Neurons (Amyotrophic Lateral Sclerosis Patient, Sporadic) Disease Model
NCL-2105-P133-IX Human iPSC-derived Motor Neurons (SOD1 mutant, A4V, HOM) Disease Model
NCL-2105-P134-IX Human iPSC-derived Motor Neurons (TDP-43 mutation, M337V, HET) Disease Model
NCL-2105-P135-IX Human iPSC-derived Motor Neurons (TDP-43 mutation, Q331K, HET) Disease Model
NCL-2105-P136-IX Human iPSC-derived Motor Neurons (TDP-43 mutation, M337V, HOM) Disease Model
NCL-2105-P137-IX Human iPSC-derived Motor Neurons (TDP-43 mutation, Q331K, HOM) Disease Model
NCL-2105-P138-IX Human iPSC-derived Motor Neurons (TDP43 mutation, N352S, HET) Disease Model
Neurons
Selected Neurons
Cutting Edge Tools for Neuroscience Research
9. Astrocytes are highly heterogeneous neuroglial cells with distinct functional and morphological characteristics in different parts
of the brain. They are responsible for maintaining a number of complex processes needed for a healthy central nervous system
(CNS).
Creative Biolabs' astrocyte precursor and mature cells are derived from neural stem cells differentiated from fully
characterized, normal karyotype human induced pluripotent stem cells (hiPSCs), using proprietary induction protocols that
produce high purity astrocytes, and using xeno-free and integration-free derivation and culturing.
• >-0% GFAP+ cells; <1% Tuj1+ cells with typical astrocyte morphology
• Characterized using immunocytochemistry and whole genome profiling
• Suitable for co-culturing with neurons for complex tissue modeling
• Limited proliferative potential and long-term viability
Human Astrocytes
Cat. Product Name Cell Type
NCL-21P6-00- Human iPSC-derived Cortical Astrocytes Primary Cell
NCL-21P6-010 Human iPSC-derived Spinal Astrocytes Primary Cell
NCL-21P6-032 Human Cerebral Cortex-derived Astrocytes Primary Cell
NCL-21P6-033 Human Cerebellum-derived Astrocytes Primary Cell
NCL-21P6-034 Human Spinal Cord-derived Astrocytes Primary Cell
NCL-21P6-035 Human Hippocampus-derived Astrocytes Primary Cell
NCL-21P6-036 Human Brain Stem-derived Astrocytes Primary Cell
NCL-21P6-037 Human Midbrain-derived Astrocytes Primary Cell
NCL-21P6-038 Human Retinal-derived Astrocytes Primary Cell
NCL2110P1-5 Human Mesencephalic-derived Astrocytes Primary Cell
NCL-21P6-14- Human Brain Astrocytes-GFP Primary Cell
NCL-21P6-150 Human Brain Astrocyte-RFP Primary Cell
NCL-2103-P01 Human Astrocytes (HA), Cryopreserved, Fetal Primary Cell
NCL-2103-P03 Human Astrocytes (HA), Cryopreserved, Adult Primary Cell
NCL-2105-P180-AM Human Astrocytes, Fetal - hTERT, Immortalized Immortalized Cell
NCL-2105-P182-AM Human Astrocytes, Fetal - SV40, Immortalized Immortalized Cell
NCL-2105-P336-AM Human Brain Astrocytes-GFP, Immortalized Immortalized Cell
NCL-2105-P340-AM Human Brain Astrocyte-RFP, Immortalized Immortalized Cell
NCL2110P065 Human Astrocyte Cell Line SVG P12, Immortalized Immortalized Cell
Mouse Astrocytes
Cat. Product Name Cell Type
NCL-21P6-064 Mouse Astrocytes from CD1 Primary Cell
NCL-21P6-065 Mouse Astrocytes from C57BL/6 Primary Cell
NCL-21P6-066 Mouse Brain Cerebellar Cortex-derived Astrocytes-from CD1 Primary Cell
NCL-21P6-067 Mouse Brain Cerebellar Cortex-derived Astrocytes-from C57BL/6 Primary Cell
NCL-21P6-071 Mouse Spinal Cord-derived Astrocytes-from CD1 Primary Cell
NCL-21P6-072 Mouse Spinal Cord-derived Astrocytes-from C57BL/6 Primary Cell
NCL-21P6-073 Mouse Brain Stem-derived Astrocytes-from CD1 Primary Cell
NCL-2105-P154-IX Mouse Midbrain-derived Astrocytes Primary Cell
NCL-2105-P155-IX Mouse Brain Hippocampus-derived Astrocytes Primary Cell
NCL-2105-P156-IX Neonatal Mouse Spinal Cord-derived Astrocytes Primary Cell
NCL-2105-P153-IX Neonatal Mouse Brain Cerebellar Cortex-derived Astrocytes Primary Cell
NCL-2105-P1---AM Mouse Astrocytes - SV40T (IMA2.1), Immortalized Immortalized Cell
Rat Astrocytes
Cat. Product Name Cell Type
NCL-21P6-076 Rat Cerebellum-derived Astrocytes Primary Cell
NCL-21P6-077 Rat Hippocampus-derived Astrocytes Primary Cell
NCL-21P6-078 Adult Rat Brain-derived Astrocytes Primary Cell
NCL-21P6-07- Rat Retinal-derived Astrocytes Primary Cell
NCC20--PZ61 Rat Brain Striatum-derived Astrocytes Primary Cell
NCC20--PZ4- Rat Brain Cortex-derived Astrocytes Primary Cell
NCL-2103-P26 Rat Cerebellar Astrocytes, Cryopreserved, Neonatal Primary Cell
NCL-2103-P11 Rat Astrocytes, Cryopreserved, Neonatal Primary Cell
NCL-2105-P173-AM Adult Rat Hippocampal Astrocytes - SV40, Immortalized Immortalized Cell
Astrocytes
Selected Astrocytes
Cutting Edge Tools for Neuroscience Research
10. Microglia are commonly described as the immune cells of the brain, with key roles in brain development, neurogenesis,
synaptic plasticity and homeostatic maintenance.
Creative Biolabs' Human iPSC-derived Microglia provide a reproducible, physiologically-relevant model in an easy-to-use, assay-
ready format for investigating neuroglia involvement in neurodegeneration and neurodevelopment. Our iPSC-derived Microglia
deliver the advantage that they provide an almost infinite source of microglia from a single donor with a normal karyotype. Our
iPSC-derived Microglia also express the microglia-specific marker TMEM11- along with myeloid markers TREM2 and IBA-1.
These phenotypes make iPSC-derived Microglia suitable models for investigating neuroinflammation in Alzheimer’s disease,
multiple sclerosis and Parkinson’s disease. We also offer a fully optimized serum-free Microglia Maintenance Medium to
promote and support the maintenance of microglia.
Human Microglia
Cat. Product Name Cell Type
NCL-7P018 iNeu™ Human iPSC-derived Microglia Primary Cell
NCL-7P016 iNeu™ Human iPSC-derived Microglia, Isogenic Control Primary Cell
NCL-2108P38 Human Microglia Cell Line HMC3, Immortalized Immortalized Cell
NCL-2105-P337-AM Human Microglia-GFP, Immortalized Immortalized Cell
NCL-2105-P341-AM Human Microglia-RFP, Immortalized Immortalized Cell
NCL-7P014 iNeu™ Microglia AD TREM2 HO, Disease Model Disease Model
NCL-7P015 iNeu™ Microglia AD TREM2 HZ, Disease Model Disease Model
NCL-7P036 iNeu™ Microglia AD APOE E4/E4, 11--5, Disease Model Disease Model
NCL-7P037 iNeu™ Microglia AD APOE E4/E4, 11--3, Disease Model Disease Model
NCL-7P038 iNeu™ Microglia AD APOE E4/E4, 12037, Disease Model Disease Model
NCL-7P03- iNeu™ Microglia AD APOE E4/E4, 12061, Disease Model Disease Model
NCL-7P040 iNeu™ Microglia AD APOE E2/E4, 11-68, Disease Model Disease Model
NCL-7P050 iNeu™ Microglia TREM2 R47H, 11-6-, Disease Model Disease Model
NCL-7P051 iNeu™ Microglia ABCA7 G1527A, 12000, Disease Model Disease Model
NCL-7P020 iNeu™ Microglia Rett Syndrome MECP2, Disease Model Disease Model
Mouse Microglia
Cat. Product Name Cell Type
NCL-21P6-081 Mouse Microglia from CD1 Primary Cell
NCL-21P6-082 Mouse Microglia from C57BL/6 Primary Cell
NCL-2103-P28 Mouse Microglia, Cryopreserved Primary Cell
NCL-2105-P210-AM Mouse Microglia SIM-A-, Immortalized Immortalized Cell
NCL-2108P32 Mouse Microglia BV-2, Immortalized Immortalized Cell
Rat Microglia
Cat. Product Name Cell Type
NCL-2105-P35--AM Rat Primary Microglia Primary Cell
NCL-2103-P1- Rat Primary Microglia, Neonatal Primary Cell
NCL2110P015 Rat Hippocampal Microglia Primary Cell
NCL-2106-S7- Rat Cochlear Microglial Cell Line Primary Cell
NCL2110P037 Rat Microglia Cell Line HAPI, Immortalized Immortalized Cell
NCL-21P6-222 Rat Cochlear Microglial Cell Line, Immortalized Immortalized Cell
Microglial Cells
Selected Microglial Cells
Cutting Edge Tools for Neuroscience Research
11. Oligodendrocytes are a type of large glial cell found in the central nervous system. Oligodendrocytes produce the myelin sheath
insulating neuronal axons (analogous to Schwann cells in the peripheral nervous system), although some oligodendrocytes
(called satellite oligodendrocytes) are not involved in myelination.
Creative Biolabs' Human Oligodendrocyte Differentiation Kit contains Human Oligodendrocyte Progenitor Cells (OPCs) along
with optimized media for their expansion and spontaneous differentiation into mature oligodendrocytes. Human OPCs can be
used for a variety of research applications including studies of neurotoxicity, co-culture applications and screening for
molecules that induce or inhibit preferential differentiation to mature oligodendrocytes.
Human Oligodendrocyte Kit
Cat. Product Name
NCL200506ZP Human Oligodendrocyte Progenitors (OPCs)
NCC200524ZP Human Oligodendrocyte Differentiation Kit
NCC200527ZP Human Oligodendrocyte Characterization Kit
Rat Oligodendrocyte
Cat. Product Name
NCL-21P6-0-4 Rat Oligodendrocyte Progenitor Cells
Oligodendrocytes
Selected Oligodendrocytes
Cutting Edge Tools for Neuroscience Research
12. Oligodendrocytes are a type of large glial cell found in the central nervous system. Oligodendrocytes produce the myelin
sheath insulating neuronal axons (analogous to Schwann cells in the peripheral nervous system), although some
oligodendrocytes (called satellite oligodendrocytes) are not involved in myelination.
Creative Biolabs' Human Oligodendrocyte Differentiation Kit contains Human Oligodendrocyte Progenitor Cells (OPCs) along
with optimized media for their expansion and spontaneous differentiation into mature oligodendrocytes. Human OPCs can be
used for a variety of research applications including studies of neurotoxicity, co-culture applications and screening for
molecules that induce or inhibit preferential differentiation to mature oligodendrocytes.
Human Schwann Cells
Cat. Product Name Cell Type
NCL-2103-P106 Human Schwann Cells Primary Cell
NCL2110P107 Human Schwann Cell, Immortalized Immortalized Cell
Mouse Schwann Cells
Cat. Product Name Cell Type
NCL-21P6-060 Mouse Schwann Cells from CD1 Primary Cell
NCL-21P6-061 Mouse Schwann Cells from C57BL/6 Primary Cell
NCL-2105-P167-IX Mouse Schwann Cells Primary Cell
NCL-2105-P223-AM Mouse Schwann Cells, Immortalized Immortalized Cell
NCL-2105-P168-AM Mouse Schwann Cells from C57BL/6, Immortalized Immortalized Cell
NCL-2105-P1-8-AM Mouse alpha-GalA-/o Schwann Cells, Immortalized Immortalized Cell
NCL-2105-P207-AM Mouse Hexb-/- Schwann Cells (1113C1), Immortalized Immortalized Cell
NCL-2105-P214-AM Mouse NPCNIH Schwann Cells (573C10), Immortalized Immortalized Cell
NCL-2108P158 Mouse Schwann Cell (1-70C3), Immortalized Immortalized Cell
NCL-2105-P224-AM Mouse Schwann Cells (IMS32), Immortalized Immortalized Cell
NCL-2105-P225-AM Mouse Schwann Cells (IKARS1), Immortalized Immortalized Cell
NCL-2105-P226-AM Mouse Schwann Cells (IWARS1), Immortalized Immortalized Cell
NCL-2108P24 Mouse Schwann Cell Line SW10, Immortalized Immortalized Cell
Rat Schwann Cells
Cat. Product Name Cell Type
NCL-21P6-0-5 Rat Schwann Cells Primary Cell
NCL-2108P05 Rat Schwann Cells RSC-6, GFP, Immortalized Immortalized Cell
NCL-2108P21 Rat Schwann Cells RSC-6, Immortalized Immortalized Cell
NCL-2105-P244-AM Rat Schwann Cells (IFRS1), Immortalized Immortalized Cell
Schwann Cells
Selected Schwann Cells
Cutting Edge Tools for Neuroscience Research
13. Translation from in vitro models & assays into animal models are critical to understanding the progression of neurological
disease while providing a complete interactive physiology to understand the pharmacokinetics and pharmacodynamics of a
candidate. We have developed robust and reproducible in vitro models and in vivo pharmacology studies that are validated for
multiple assay platforms and reliable tools to screen small molecules to biologics.
Applications of Cell-Based Models:
DISEASE MODELING. Generate patient-specific human "disease-in-a-dish" models.
DRUG DISCOVERY. Screen drug candidates on physiologically relevant human cell types, including diseased cells.
TOXICITY SCREENING. Evaluate neurotoxicity on differentiated human neural cell types.
CELL THERAPY VALIDATION. Generate human neural cell types for pre-clinical validation of potential cell therapy applications.
Selected Neurological Disease Cell Models
Gene-edited Disease Model
Cat. Product Name Disease Cell Type
NCL-7P001 iNeu Motor Neurons ALS TDP43 Q331K, Disease Model Amyotrophic Lateral Sclerosis Gene-edited Disease Model
NCL-7P002 iNeu Motor Neurons ALS TDP43 M337V, Disease Model Amyotrophic Lateral Sclerosis Gene-edited Disease Model
NCL-7P004 iNeu Motor Neurons ALS TDP43 Q331K Kit, Disease Model Amyotrophic Lateral Sclerosis Gene-edited Disease Model
NCL-7P005 iNeu Motor Neurons ALS TDP43 M337V Kit, Disease Model Amyotrophic Lateral Sclerosis Gene-edited Disease Model
NCL-2105-P133-IX iNeu Motor Neurons (SOD1 mutant, A4V, HOM) Amyotrophic Lateral Sclerosis Gene-edited Disease Model
NCL-7P012 iNeu Microglia AD TREM2 HO Kit, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P013 iNeu Microglia AD TREM2 HZ Kit, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P014 iNeu Microglia AD TREM2 HO, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P015 iNeu Microglia AD TREM2 HZ, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P031 iNeu Microglia AD APOE E4/E4 Kit, 11--3, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P032 iNeu Microglia AD APOE E4/E4 Kit, 11--5, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P033 iNeu Microglia AD APOE E4/E4 Kit, 12037, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P034 iNeu Microglia AD APOE E4/E4 Kit, 12061, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P035 iNeu Microglia AD APOE E2/E4 Kit, 11-68, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P036 iNeu Microglia AD APOE E4/E4, 11--5, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P037 iNeu Microglia AD APOE E4/E4, 11--3, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P038 iNeu Microglia AD APOE E4/E4, 12037, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P03- iNeu Microglia AD APOE E4/E4, 12061, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P040 iNeu Microglia AD APOE E2/E4, 11-68, Disease Model Alzheimer’s Disease Gene-edited Disease Model
NCL-7P026 iNeu DopaNeurons PD SNCA A53T HZ Kit, Disease Model Parkinson’s Disease Gene-edited Disease Model
NCL-7P027 iNeu DopaNeurons PD SNCA A53T HZ, Disease Model Parkinson’s Disease Gene-edited Disease Model
NCL-7P020 iNeu Microglia Rett Syndrome MECP2, Disease Model Rett Syndrome Gene-edited Disease Model
NCL-2101-ZP06 iNeu Neural Stem Cells - AD Patient (APOE4 HOM) Alzheimer’s Disease Gene-edited Disease Model
NCL-2101-ZP07 iNeu Neural Stem Cells - AD Patient (PSEN1 L286V) Alzheimer’s Disease Gene-edited Disease Model
NCL-2101-ZP08 iNeu Neural Stem Cells - AD Patient (PSEN1 M146L) Alzheimer’s Disease Gene-edited Disease Model
NCL-2101-ZP0- iNeu Neural Stem Cells - AD Patient (PSEN1 A246E) Alzheimer’s Disease Gene-edited Disease Model
Neurological Disease Cell Models
Cutting Edge Tools for Neuroscience Research
14. Donor-derived Disease Model
Cat. Product Name Disease Cell Type
NRZP-0622-P28 iNeu™ Human Neural Stem Cells - Alzheimer’s Disease Patient, Donor 1 Alzheimer’s Disease Donor-derived Disease Model
NRZP-0622-P31
iNeu™ Human Neural Stem Cells - Frontotemporal Dementia (FTD) Patient,
Donor 4
Frontotemporal Dementia (FTD) Donor-derived Disease Model
NRZP-0622-P33
iNeu™ Human Neural Stem Cells - Frontotemporal Dementia (FTD), Paget’s
Disease Patient, Donor 6
Frontotemporal Dementia (FTD),
Paget’s Disease
Donor-derived Disease Model
NRZP-0622-P35
iNeu™ Human Neural Stem Cells - Frontotemporal Dementia, ALS Patient,
Donor 8
Frontotemporal Dementia,
Amyotrophic Lateral Sclerosis
Donor-derived Disease Model
NRZP-0622-P37
iNeu™ Human Neural Stem Cells - Behavioural Variant Frontotemporal
Dementia (bvFTD) Patient, Donor 10
Behavioural Variant
Frontotemporal Dementia (bvFTD)
Donor-derived Disease Model
NRZP-0622-P41 iNeu™ Human Neural Stem Cells - Mucolipidosis IV (ML4) Patient, Donor 14 Mucolipidosis IV (ML4) Donor-derived Disease Model
NRZP-0622-P45 iNeu™ Human Neural Stem Cells - Nasu-Hakola Disease Patient, Donor 18 Nasu-Hakola Disease Donor-derived Disease Model
NRZP-0622-P47
iNeu™ Human Neural Stem Cells - Nasu-Hakola Disease (familial control)
Patient, Donor 20
Nasu-Hakola Disease (familial
control)
Donor-derived Disease Model
NRZP-0622-P48 iNeu™ Human Neural Stem Cells - Parkinson’s Disease Patient, Donor 21 Parkinson’s Disease Donor-derived Disease Model
NRZP-0622-P5-
iNeu™ Human Neural Stem Cells - Parkinsonism/Machado-Joseph Disease
(SCA3) Patient, Donor 32
Parkinsonism/MachAlzheimer’s
Diseaseo-Joseph Disease (SCA3)
Donor-derived Disease Model
NRZP-0622-P63
iNeu™ Human Neural Stem Cells - Amyotrophic Lateral Sclerosis (ALS) Patient,
Donor 36
Amyotrophic Lateral Sclerosis
(Amyotrophic Lateral Sclerosis)
Donor-derived Disease Model
NRZP-0622-P65
iNeu™ Human Neural Stem Cells - Amyotrophic Lateral Sclerosis (ALS)
(unaffected) Patient, Donor 38
Amyotrophic Lateral Sclerosis
(Amyotrophic Lateral Sclerosis)
(unaffected)
Donor-derived Disease Model
NRZP-0622-P66
iNeu™ Human Neural Stem Cells - Charcot-Marie-Tooth Disease, Type 4J
(CMT4J) Patient, Donor 3-
Charcot-Marie-Tooth Disease,
Type 4J (CMT4J)
Donor-derived Disease Model
NRZP-0622-P67
iNeu™ Human Neural Stem Cells - Dentatorubral-Pallidoluysian Atrophy (DRPLA)
Patient, Donor 40
Dentatorubral-Pallidoluysian
Atrophy (DRPLA)
Donor-derived Disease Model
NRZP-0622-P71 iNeu™ Human Neural Stem Cells - Friedreich’s Ataxia Patient, Donor 44 Friedreich’s Ataxia Donor-derived Disease Model
NRZP-0622-P75
iNeu™ Human Neural Stem Cells - Friedreich’s Ataxia (control) Patient, Donor
48
Friedreich’s Ataxia (control) Donor-derived Disease Model
NRZP-0622-P76
iNeu™ Human Neural Stem Cells - Friedreich’s Ataxia (familial control) Patient,
Donor 4-
Friedreich’s Ataxia (familial control) Donor-derived Disease Model
NRZP-0622-P77 iNeu™ Human Neural Stem Cells - Huntington’s Disease Patient, Donor 50 Huntington’s Disease Donor-derived Disease Model
NRZP-0622-P80
iNeu™ Human Neural Stem Cells - Huntington’s Disease RCi004-B Patient,
Donor 53
Huntington’s Disease RCi004-B Donor-derived Disease Model
NRZP-0622-P82
iNeu™ Human Neural Stem Cells - Spinal and Bulbar Muscular Atrophy (SBMA)
Patient, Donor 55
Spinal and Bulbar Muscular
Atrophy (SBMA)
Donor-derived Disease Model
NRZP-0622-P83
iNeu™ Human Neural Stem Cells - Spinocerebellar Ataxia Type 2 (SCA2) Patient,
Donor 56
Spinocerebellar Ataxia Type 2
(SCA2)
Donor-derived Disease Model
NRZP-0622-P8-
iNeu™ Human Neural Stem Cells - Spinocerebellar Ataxia Type 7 (SCA7) Patient,
Donor 62
Spinocerebellar Ataxia Type 7
(SCA7)
Donor-derived Disease Model
NRZP-0622-P-0
iNeu™ Human Neural Stem Cells - Spinocerebellar Ataxia Type 6 (SCA6) Patient,
Donor 63
Spinocerebellar Ataxia Type 6
(SCA6)
Donor-derived Disease Model
NRZP-0622-P-1
iNeu™ Human Neural Stem Cells - Spinocerebellar Ataxia Type 3 (SCA3) Patient,
Donor 64
Spinocerebellar Ataxia Type 3
(SCA3)
Donor-derived Disease Model
NCL-2105-P130-IX iNeu Human Motor Neurons - ALS Patient, Sporadic Amyotrophic Lateral Sclerosis Donor-derived Disease Model
NCL-2101-ZP11 iNeu Human Neural Stem Cells - Epilepsy Patient Epilepsy Donor-derived Disease Model
NCL-2101-ZP12 iNeu Human Neural Stem Cells - Trisomy X Patient Trisomy X Donor-derived Disease Model
NCL-2108-P007 iNeu Human Neural Progenitor Cell Line, AD Patient Alzheimer’s Disease Donor-derived Disease Model
Neurological Disease Cell Models
Cutting Edge Tools for Neuroscience Research
Assay Cell Line Models
Cat. Product Name Cell Type
NCL2110P230 APP Processing Assay Cell Line [Alzheimer’s Disease (AD) Model] Assay Model
NCL2110P231 FUS/TLS Stress Granules Assay Cell Line [Amyotrophic Lateral Sclerosis (ALS) Model] Assay Model
NCL2110P232 Gamma Secretase Activity Assay Cell Line [Alzheimer’s Disease (AD) Model] Assay Model
NCL2110P234 Parkin Mitochondrial Recruitment Assay Cell Line [Parkinson’s Disease (PD) Model] Assay Model
NCL2110P235 Tau Phosphorylation Assay Cell Line [Alzheimer’s Disease (AD) Model] Assay Model
NCL2110P236 TDP-43 Stress Granules Assay Cell Line [Amyotrophic Lateral Sclerosis (ALS) Model] Assay Model
NCL2110P337 Parkinsonism Cell Line, Disease Model Assay Model
15. Extensive Neural Tissue Biorepository from Healthy and Diseased Donors !
Creative Biolabs offers a comprehensive repository of neural tissue samples, covering multiple regions of the brain and spinal
cord from many species and tissue types. Certified tissues are available as OCT frozen blocks & snap-frozen samples, FFPE
blocks, FFPE tissue arrays, frozen tissue arrays, frozen tissue sections, FFPE tissue sections, FFPE tissue panels, as well as
fresh tissue. We have a wide range of donors and provide both healthy and diseased tissue.
Also available: Total RNA– cDNA– Genomic DNA– Total Protein
Human Tissue
- Adult and Fetal Normal
- Tumour and Adjacent Tissue
- Diseased tissues including Alzheimer's Disease, Parkinson's Disease and Dementia
Multiple Species Available
Tissue Dissociation:
Creative Biolabs has developed Neural Tissue Dissociation Kits used for the gentle and efficient generation of single-cell
suspensions from neural tissues. The Neural Tissue Dissociation Kit - Postnatal Neurons has been optimized for the special
needs of sensitive postnatal neurons during dissociation. We also offers highly purified collagenase free of any animal-based
components. For research applications, non-GMP grade Collagenase NB4 Standard Grade and Collagenase NB 5 Sterile Grade
are economical alternatives with comparable enzymatic properties to Collagenase NB 6 GMP Grade.
Ordering Information:
- Mouse
- Rhesus Monkey
- Cynomolgus Monkey
- Marmoset
- Guinea Pig
- Cat
- Chicken
- Dog
- Horse
- Bovine
- Rat
- Rabbit
- Hamster
- Nude Mouse
- Mini Pig
- Pig
Cat. Product Name
NRZP-0622-ZP15 Neural Tissue Dissociation Kit (P) – Postnatal Neurons
NRZP-0622-ZP16 Neural Tissue Dissociation Kit (T) – Postnatal Neurons
NRZP-0622-ZP17 Brain Tumor Dissociation Kit (P), Human and Mouse
NRZP-0622-ZP14 Adult Brain Dissociation Kit, Mouse and Rat
NRZP-0622-ZP390 Collagenase NB 4 Standard Grade
NRZP-0622-ZP389 Collagenase NB 5 Sterile Grade
NRZP-0622-ZP394 Collagenase NB 6 GMP Grade
NRZP-0622-ZP396 Neutral Protease NB GMP Grade
Neural Tissues
Cutting Edge Tools for Neuroscience Research
16. We supply neural cell culture medium optimized to support undifferentiated growth both as adherent cultures or neurosphere
suspensions. We also provide medium, supplements and growth factors to differentiate neural stem cells and to maintain long-
term cultures of differentiated cells. In addition to culture mediums, Creative Biolabs also supplies all supporting reagents to
characterize neural stem cells including nestin antibodies as well as differentiated neurons using βIII-tubulin antibodies,
oligodendrocytes using O3 antibodies and astrocytes using GFAP antibodies.
Ordering Information:
Growth Medium
Cat. Product Name
CAT#: NCC20-9PZ02 Astrocyte Growth Medium
NCL-21P6-226 Microglial Cell Growth Medium
NCC-2101-ZP14 Striatal Neuron Growth Medium
NRZP-0522-ZP1151 Oligodendrocyte Growth Media
NCL-21P6-105 Oligodendrocyte Precursor Cell Growth Medium
NCC20-9PZ10 Primary Neuron Growth Medium
NCC2009PZ17 Retinal Pigment Epithelial Cell Growth Medium Kit
NCC20-9PZ26 Endothelial Cell Growth Medium
NCC-2103-P65 Schwann Growth Medium
NCL-2105-P140-IX Human Neural Stem Cell Growth Medium
Maintenance Medium
Cat. Product Name
NCC200631ZP StemTes™ A Maintenance Medium
NCC-2101-ZP26 Microglia Maintenance Medium
NCC-2101-ZP15 Sensory Neuron Maintenance Medium
NCC-2101-ZP24 Motor Neuron Maintenance Medium
NCC-2101-ZP25 Astrocyte Maintenance Medium
NCL-2105-P119-IX Cortical Neuron Maintenance Medium
Differentiation Medium
Cat. Product Name
NCL-21P6-106 Oligodendrocyte Precursor Cell Differentiation Medium
NCC200538ZP ES/iPS Neuronal Differentiation Medium
Neural Supplements
Cat. Product Name
NCL-7P062 Nervous System Supplement
NCL-21P6-124 Astrocyte Growth Supplement
NCL-21P6-118 Epithelial Cell Growth Supplement
NCL-21P6-116 Fibroblast Growth Supplement
NCL-21P6-114 Endothelial Cell Growth Supplement
NCC200512ZP NeuroInduc™ Neural Stem and Progenitor Cells Differentiation Supplement
NCC200600ZP NeuroInduc™ N2 Supplement-A
NCC200605ZP NeuroInduc™ N2 Supplement-B
NRZP-0622-ZP403 GS21 Neural Supplement
NCC-2101-ZP17 Human/Murine/Rat BDNF [CAT#:]
NCC-2101-ZP19 Human beta-NGF
NCC-2101-ZP20 Human NT-3
Neural Cell Culture Media and Supplements
Cutting Edge Tools for Neuroscience Research
17. Laminin for Neural Cell Attachment
Laminins (heterotrimers composed of α, β, and γ chains), are
multifunctional glycoproteins present in basement membranes. Laminin
has long been an important mainstay of neural cell culture as coating
substrates and is also used as a supplement of culture medium to
enhance growth of human neural stem cells. We provide a range of high
quality laminin products that are ideally suited as tools for neural cell
culture to allow you to select the most suitable version for your research.
Cat. Product Name
NRZP-0622-ZP398 Mouse Laminin I
NRZP-0622-ZP399 Antibiotic-Free Mouse Laminin I
NRZP-0622-ZP400 Stem Cell Qualified Mouse Laminin I
NRZP-0622-ZP401 3D Culture Matrix Laminin I
NRZP-0622-ZP402 Poly-D-Lysine & Laminin Coating Solution
Extracellular Matrix for Neurosphere Formation
Neurospheres demonstrated the first unequivocal evidence that cells derived
from adult brain can have stem cell properties and remain a useful tool for
the in vitro study of neural stem cells. Applications include analysis of
selfrenewal capacity, potency, neural development and neurogenesis. We
provide an optimized spheroid formation matrix to help with consistent
generation of neurospheres for use in your research.
Ordering Information:
Cat. Product Name
NRZP-0622-ZP397 Neurosphere Formation Matrix
Neural Cell Culture Matrices
Ordering Information:
18. Optimized transfection reagents tailored for neural cells!
Physiologically relevant models, such as primary neurons and small animal models, increase the need for new nucleic acid
delivery tools. One of the greatest challenges is the ability to manipulate the desired cell models that are traditionally difficult to
transfect, including primary neurons and neural stem cells. Methods typically used have not met these needs—reagent-
mediated DNA transfection is inefficient for nuclear entry; electroporation requires cell disruption and special instrumentation,
and is expensive; and virus-mediated transduction can be very time-consuming. To facilitate the use of more relevant cell
models, we have developed NeuroIn™ Transfection Reagent, which we recommend as the primary gene delivery solution (Fig.1).
Figure 1. Recommended transfection methods, by cell type.
Cat. Product Name
NRZP-0622-ZP377 NeuroIN™ mRNA Transfection Reagent
NRZP-0622-ZP378 NeuroIN™ DNA Transfection Reagent, Lipo 3000
NRZP-0622-ZP37- NeuroIN™ DNA Transfection Reagent, Lipo 2000
NRZP-0622-ZP380 NeuroIN™ Invivo Brain Transfection Reagent, 3.0
NRZP-0622-ZP381 NeuroIN™ RNAi Transfection Reagent
Product Nucleic acid type Cell model Performance Cell viability Ease of use
NeuroIN™ mRNA Transfection Reagent mRNA
Primary cells, stem cells, and difficult-to-
transfect cells
+++ ++++ ++++
NeuroIN™ DNA Transfection Reagent, Lipo 3000 DNA
Easy- and difficult-to-transfect immortalized
cell lines, viral delivery
++ ++++ ++++
NeuroIN™ DNA Transfection Reagent, Lipo 2000 DNA Easy-to-transfect cells, primary neurons + ++++ ++++
NeuroIN™ Invivo Brain Transfection Reagent, 3.0 siRNA, mRNA In vivo directbraininjection ++ ++ ++
NeuroIN™ RNAi Transfection Reagent siRNA All neuronal cell models (gene knockdown) ++++ ++++ ++++
Neural Cell Transfection
Ordering information:
Product selection guide
We offer a variety of other gene delivery options based on your research needs, including lentiviral delivery and physical
methods such as electroporation. However, there are advantages and limitations for each method based on the cell models
being used and the end goal of the experiment: gene expression or gene knockdown. An overview of our most effective
delivery solutions for neurobiology research is shown in Table 1.
Table 1. Gene delivery products for neurobiology research by nucleic acid type.
Cutting Edge Tools for Neuroscience Research
19. Keeping your cells safe with the CELLBANKER Series!
There are numerous protocols available for cryopreserving neural stem cells (NSCs) derived from human embryonic stem cells;
the primary objective of these methods are the recovery of the cells post-thaw and the retention of their multipotent properties.
Creative Biolabs supplies cutting edge cryopreservation reagents to meet the demands of your neural cell research. Our high
performance and quality assured CELLBANKER cryopreservation solutions ensure stable long-term storage of cells.
CELLBANKER is a series of easy-to-use cell freezing media with defined formulations, available in serum and serum-free
formulations to successfully cryopreserve the most sensitive mammalian cells.
Figure 1. Recommended transfection methods, by cell type.
Product selection guide
- CELL-BANKER 1 was launched in 1--2 and now has a significant history of reliable, consistent
and high viability recoveries post-cryopreservation. Contains serum, DMSO, glucose, salts and buffer.
- CELLBANKER 2 is a chemically defined serum-free cell freezing medium that allows cell cryopreservation
directly at -80˚C without requiring a rate controlled freezer. Contains no animal derived products and is
guaranteed sterile.
- STEM-CELLBANKER is a chemically defined xeno-free freezing medium optimized for stem cells and iPS
cells storage as well as other valuable cells. It is free of serum and animal derived components and contains
only European or US Pharmacopoeia graded ingredients. Use STEM-CELLBANKER to achieve consistently high
cell viability post-thaw, even over extended long-term storage, while maintaining cell pluripotency, normal
karyotype and proliferation ability.
Ordering information:
Cat. Product Name
NRZP-0622-ZP382 CELLBANKER 1 (100ml)
NRZP-0622-ZP383 CELLBANKER 2 (100ml)
NRZP-0622-ZP384 STEM-CELLBANKER - GMP Grade (20ml)
Neural Cell Cryopreservation
Cutting Edge Tools for Neuroscience Research
20. SUITE 203, 17 Ramsey Road, Shirley, NY 11-67, USA
Tel: 1-631-357-2254
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
167-16-Great Portland Street, 5th Floor, London, W1W 5PF
Tel: 44-207-0-7-1828
Email: info@creative-biolabs.com
USA UK